Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Liver exchanges : Nyse save search
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published: 2024-02-12 (Crawled : 20:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.32%
H: 0.11%
C: -1.55%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -2.63%
H: 0.98%
C: -1.75%
liver disease therapeutics market
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 1.29%
H: 0.35%
C: -3.04%
HEPA | News | $2.11 -0.09% -0.09% 73K
|
Health Technology
|
| O: -0.48%
H: 7.69%
C: 1.44%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -0.8%
H: 6.02%
C: 0.6%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.46%
H: 3.04%
C: 2.67%
ETNB | $9.08 2.25% 2.2% 1M
|
Health Technology
|
| O: 1.19%
H: 0.63%
C: -0.72%
liver disease companies key growth market
Global NASH Market to Soar to $2.71 Billion by 2023, Driven by Rising Prevalence of Silent Liver Disease
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
IVA | $3.35 -2.9% -2.99% 8.5K
|
Health Technology
| Email alert
Add to watchlist
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
| Email alert
Add to watchlist
GNFT | $3.59 4.03% 2.1K
|
Health Technology
| Email alert
Add to watchlist
ICPT | $19.0 -0.05% 4M
|
Health Technology
| Email alert
Add to watchlist
IVEVF | $3.73 0% 1K
|
n/a
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
GLMD | $0.3787 -0.41% 18K
|
Health Technology
| Email alert
Add to watchlist
liver disease global nash market
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: 1.18%
H: 1.81%
C: 0.52%
liver disease report health pharmaceuticals trends
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
Published: 2023-07-17 (Crawled : 13:20) - biospace.com/
TVTX | $5.73 -1.21% -1.22% 950K
|
Health Technology
|
| O: 5.16%
H: 0.75%
C: -1.43%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: -0.12%
H: 1.42%
C: 0.81%
MIRM | News | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 1.18%
H: 7.3%
C: 2.18%
rare liver treatment pharmaceuticals acquire therapeutics agreement
Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight
Published: 2023-07-12 (Crawled : 21:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.7%
H: 0.01%
C: -0.32%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.08%
H: 0.46%
C: -1.26%
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 0.41%
H: 3.34%
C: 1.43%
LPCN | $5.33 -2.02% -2.06% 11K
|
Health Technology
|
| O: 0.11%
H: 2.15%
C: 1.02%
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
|
| O: 0.64%
H: 7.01%
C: 5.1%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.69%
H: 1.02%
C: 0.29%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.78%
H: 1.1%
C: -0.15%
cirrhosis liver growth market
Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023
Published: 2023-06-19 (Crawled : 13:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
| Email alert
Add to watchlist
liver international research
Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist, in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) at EASL 2023
Published: 2023-06-12 (Crawled : 12:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: -0.47%
H: 0.73%
C: -0.3%
mk-6024 liver disease merck
Liver Cancer Drugs Market size to grow at a CAGR of 14.67% from 2021 to 2026, Driven by the growing incidence of liver cancer - Technavio
Published: 2023-04-12 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 5.41%
H: 0.0%
C: -2.14%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.57%
C: 3.57%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.75%
H: 0.5%
C: -0.05%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.96%
H: 0.71%
C: 0.22%
liver cancer growing market
First Patient Treated in Alpha-1 Antitrypsin Deficiency Liver Disease Phase 3 Study Triggering $40 Million Milestone Payment from Takeda to Arrowhead
Published: 2023-04-04 (Crawled : 17:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.12%
H: 1.55%
C: 1.03%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: 0.67%
H: 0.08%
C: -2.22%
liver disease payment milestone study
Global Liver Disease Market, Global Forecast 2023-2027: Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis
Published: 2023-02-14 (Crawled : 15:20) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.01%
H: 0.14%
C: -0.43%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.3%
H: 0.14%
C: -0.86%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
liver global disease impact
Global Liver Cancer Drugs Strategic Market Report to 2030: Targeted Therapies Grow in Popularity
Published: 2023-02-11 (Crawled : 16:20) - prnewswire.com
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
liver global report cancer market
Liver cancer drugs market size to grow by USD 5.29 billion from 2021 to 2026: A descriptive analysis of customer landscape, vendor assessment, and market dynamics - Technavio
Published: 2023-02-09 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.07%
H: 1.75%
C: 0.35%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: -4.0%
H: 4.17%
C: 4.17%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.87%
H: 0.17%
C: -1.53%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 6.13%
H: 0.42%
C: -1.3%
liver cancer market
Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
Published: 2023-02-01 (Crawled : 15:00) - biospace.com/
MIRO | $3.39 3.25% 630K
|
Professional, Scientific, and T...
|
| O: -0.57%
H: 5.19%
C: -9.8%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.44%
H: 1.04%
C: 0.85%
care research liver agreement
Arrowhead and Takeda Announce Topline Results from SEQUOIA Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Published: 2023-01-09 (Crawled : 13:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.13%
H: 0.38%
C: -0.19%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: -19.61%
H: 3.16%
C: 0.77%
liver disease topline results study
iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
Published: 2022-11-30 (Crawled : 14:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.1%
H: 0.56%
C: 0.56%
DTIL | $9.75 -9.05% -9.95% 170K
|
Health Technology
|
| O: 1.54%
H: 4.55%
C: 3.79%
treatment rare liver
SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION
Published: 2022-10-12 (Crawled : 12:20) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.3%
H: 2.58%
C: 2.12%
pharmaceuticals liver trends disease report growing health
Liver Fibrosis Market to Surge at a CAGR of 15.9% by 2032 | DelveInsight
Published: 2022-09-05 (Crawled : 16:00) - prnewswire.com
SGMT | $4.0 0.76% 0.75% 430K
|
Health Technology
| Email alert
Add to watchlist
ETNB | $9.08 2.25% 2.2% 1M
|
Health Technology
| Email alert
Add to watchlist
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
| Email alert
Add to watchlist
LPCN | $5.33 -2.02% -2.06% 11K
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
| Email alert
Add to watchlist
fibrosis liver market
Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published: 2022-06-21 (Crawled : 03:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 6.34%
H: 0.0%
C: -4.65%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 4.65%
H: 0.0%
C: -4.51%
QBIO | $0.0002 100.0% 1.1K
|
Professional, Scientific, and T...
|
| O: 46.85%
H: 0.0%
C: -30.95%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 2.03%
H: 0.0%
C: 0.0%
research liver cancer market
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL's International Liver Congress™ 2022
Published: 2022-06-20 (Crawled : 12:00) - biospace.com/
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
| Email alert
Add to watchlist
xifaxan research liver international
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.